Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/petr.13972 http://scihub22266oqcxt.onion/10.1111/petr.13972 33502074!7994962!33502074     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Pediatr+Transplant 2021 ; 25 (5): e13972 Nephropedia Template TP {{tp|p=33502074|t=2021. An early experience of COVID-19 disease in pediatric and young adult renal transplant recipients |pdf=|usr=}}{{33502074}} gab.com Text An early experience of COVID-19 disease in pediatric and young adult renal transplant recipients JO: Pediatr Transplant http://www.kidney.de/pget.php?&tw=1&pmid=33502074 #FOAvip BACKGROUND: COVID-19 is caused by a novel form of coronavirus known as SARS-CoV-2. Patients can present with a wide variety of symptoms from fever to severe respiratory distress. Immunocompromised patients, including solid organ transplant recipients, may present with atypical symptoms, making the diagnosis of COVID-19 more difficult to make. New reports have been emerging about the management of COVID-19 disease in adult renal transplant recipients. However, very little is known in pediatric renal transplant recipients. METHODS: Here, we describe a case report of four pediatric renal transplant recipients who presented with mild-to-moderate COVID-19 disease. RESULTS: All patients presented with upper respiratory infection symptoms, with one requiring hospitalization for hypoxia. Patients were treated mostly with supportive care. Two of the patients developed AKI which resolved four to eight weeks after illness. All four patients developed COVID IgG antibodies one to two months after becoming infected. CONCLUSION: This case series demonstrates that immunocompromised renal transplant recipients have comparable outcomes compared with immunocompetent children. Twit Text FOAVip An early experience of COVID-19 disease in pediatric and young adult renal transplant recipients ????Pediatr Transplant http://www.kidney.de/pget.php?&tw=1&pmid=33502074 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33502074 #FOAvip English Wikipedia <ref>{{Cite pmid|33502074}}</ref> An early experience of COVID-19 disease in pediatric and young adult renal transplant recipients #MMPMID33502074 Solomon S; Pereira T; Samsonov D Pediatr Transplant 2021[Aug]; 25 (5): e13972 PMID33502074show ga BACKGROUND: COVID-19 is caused by a novel form of coronavirus known as SARS-CoV-2. Patients can present with a wide variety of symptoms from fever to severe respiratory distress. Immunocompromised patients, including solid organ transplant recipients, may present with atypical symptoms, making the diagnosis of COVID-19 more difficult to make. New reports have been emerging about the management of COVID-19 disease in adult renal transplant recipients. However, very little is known in pediatric renal transplant recipients. METHODS: Here, we describe a case report of four pediatric renal transplant recipients who presented with mild-to-moderate COVID-19 disease. RESULTS: All patients presented with upper respiratory infection symptoms, with one requiring hospitalization for hypoxia. Patients were treated mostly with supportive care. Two of the patients developed AKI which resolved four to eight weeks after illness. All four patients developed COVID IgG antibodies one to two months after becoming infected. CONCLUSION: This case series demonstrates that immunocompromised renal transplant recipients have comparable outcomes compared with immunocompetent children. |*SARS-CoV-2[MESH] |Adolescent[MESH] |COVID-19/complications/*diagnosis/immunology/*therapy[MESH] |Female[MESH] |Fever[MESH] |Humans[MESH] |Hypoxia[MESH] |Immunocompromised Host[MESH] |Immunoglobulin G[MESH] |Kidney Transplantation/*methods[MESH] |Male[MESH] |Renal Insufficiency/complications/surgery[MESH] |Transplant Recipients[MESH]An early experience of COVID-19 disease in pediatric and young adult r(epmc).pdf DeepDyve Pubget Overpricing